Qiagen N.V. (LON:0RLT)

Market Cap	6.83B
Revenue (ttm)	1.58B
Net Income (ttm)	66.77M
Shares Out	n/a
EPS (ttm)	0.30
PE Ratio	102.30
Forward PE	n/a
Dividend	1.01 (2.72%)
Ex-Dividend Date	Jan 29, 2025

Volume	21,431
Average Volume	81,335
Open	37.88
Previous Close	37.58
Day's Range	37.02 - 37.90
52-Week Range	30.27 - 39.91
Beta	0.62
RSI	52.88
Earnings Date	Apr 28, 2025

About Qiagen

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally. The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids; and...

• Industry: Laboratory Analytical Instruments
• Founded: 1984
• Employees: 5,396
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RLT

Financial Performance

In 2024, Qiagen's revenue was $1.98 billion, an increase of 0.66% compared to the previous year's $1.97 billion. Earnings were $83.59 million, a decrease of -75.51%.

Financial numbers in USD